Development of radiotracers for tumor and inflammation imaging
(in collaboration with the Radiopharmacy Laboratory)
- Radiolabeled small molecule-based ligands for active targeting of tumors expressing the cholecystokinin 2 receptor
- In vivo imaging of over-expressed micro-RNAs for lung cancer diagnosis and prognosis.
Ultimo aggiornamento: 12/01/24